-
公开(公告)号:US11738053B2
公开(公告)日:2023-08-29
申请号:US16329915
申请日:2017-09-01
发明人: Senlin Li , Robert A Clark , Cang Chen , Yang Li
CPC分类号: A61K35/28 , A01K67/0276 , A61K38/193 , C12N15/86 , A01K2227/105 , A01K2267/0306 , C12N2740/16043
摘要: The invention relates to a method of treating chronic granulomatous disease through Hematopoietic stem cell (HSC) transplantation. The method comprises the steps of administering stem cell mobilization agent to human such that the target stem cell population migrates from host niches into the subject's blood. The target stem cells are removed from blood and administering the therapeutic stem cells to human and said therapeutic stem cells are engineered to express gp91phox. The steps are repeated multiple times i.e. at least four times. The mobilization agents used in the invention are granulocyte-colony stimulating factor and AMD3100. The method of HSC transplantation is effective in treatment of chronic granulomatous disease.